Harvard Bioscience (HBIO) Gross Profit (QoQ) (2010 - 2026)
Harvard Bioscience (HBIO) Gross Profit (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.05 Bn | 120.83 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 44.78 Bn | 43.96 Bn | 2.15 Bn |
| 3 | Alcon | 32.95 Bn | 31.30 Bn | 1.53 Bn |
| 4 | Medline | 32.84 Bn | 30.60 Bn | 1.84 Bn |
| 5 | Resmed | 29.46 Bn | 27.80 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 23.59 Bn | 23.15 Bn | 329.20 Mn |
| 7 | Solventum | 14.02 Bn | 13.45 Bn | 1.10 Bn |
| 8 | Cooper Companies | 13.77 Bn | 13.64 Bn | 735.40 Mn |
| 9 | Align Technology | 12.06 Bn | 11.00 Bn | 736.59 Mn |
| 10 | Harvard Bioscience | 26.75 Mn | 19.65 Mn | 12.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.60% |
| Dec 31, 2025 | 17.89% |
| Sep 30, 2025 | 4.23% |
| Jun 30, 2025 | -5.34% |
| Mar 31, 2025 | -13.04% |
| Dec 31, 2024 | 9.76% |
| Sep 30, 2024 | -3.43% |
| Jun 30, 2024 | -10.52% |
| Mar 31, 2024 | -9.51% |
| Dec 31, 2023 | 10.85% |
| Sep 30, 2023 | -11.67% |
| Jun 30, 2023 | -9.12% |
| Mar 31, 2023 | 15.87% |
| Dec 31, 2022 | 30.08% |
| Sep 30, 2022 | -26.84% |
| Jun 30, 2022 | 2.84% |
| Mar 31, 2022 | -17.30% |
| Dec 31, 2021 | 19.94% |
| Sep 30, 2021 | -0.28% |
| Jun 30, 2021 | 5.97% |